TITLE:
Reduction in the Occurrence of Center-Involved Diabetic Macular Edema

CONDITION:
Diabetic Retinopathy

INTERVENTION:
ruboxistaurin

SUMMARY:

      The purpose of this study is to determine if ruboxistaurin can help slow the worsening of an
      eye disease called macular edema in patients with diabetes.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Type 1 or Type 2 diabetes

          -  18 years or older

          -  Non-clinically significant diabetic macular edema

          -  Mild to moderate diabetic retinopathy in the study eye, vitreous hemorrhage in the
             study eye

          -  Relatively good vision (20/30 or better)

        Exclusion Criteria:

          -  Surgery or laser treatment in the study eye

          -  Glaucoma in the study eye

          -  Glycosylated hemoglobin (HbA1c) greater than 11%, or systolic blood pressure greater
             than 170 millimeters of mercury (mmHg)

          -  Liver disease, dialysis or renal transplant
      
